91

020 7713 0990
020 7713 0990
Wednesday, 11 June 2025

DNA methylation analysis could help predict outcomes for children with T-cell acute lymphoblastic leukaemia, Swedish researchers have reported, which they say could improve the precision of treatment and reduce side effects.

Methylation is a chemical change to DNA which can control the activity of genes found at different locations in the genome.

The researchers carried out a retrospective analysis of disease progression in some 348 children recently treated in northern Europe for T-cell acute lymphoblastic leukaemia (T-ALL) over a period of 12 years. This led to analysis of about 850,000 DNA methylation positions.

The project has also involved establishing an epigenetic analysis base in Umeå, Sweden.

The researchers, led by a team at Umeå University, have published their work in the journal Blood. They say they are adapting processes already developed for the diagnosis of brain cancer.

They report that methylation analysis improved risk assessment by measurable residual disease (MRD) testing, and has the potential to guide therapeutic decisions.

Study leader Professor Sofie Degerman said: “The healthcare system has become much better at saving lives in childhood leukaemia, but the downside of intensive treatments is severe side effects.

“Our results show that DNA methylation analysis may be a viable way to individualise treatment according to the type of leukaemia, with the hope of a better quality of life.”

Source:

Schäfer Hackenhaar F, Refhagen N, Hagleitner M, van Leeuwen F, Marquart HV, Madsen HO, Landfors M, Osterman P, Schmiegelow K, Flaegstad T, Jónsson Ó, Kanerva J, Abrahamsson J, Heyman M, Norén Nyström U, Hultdin M, Degerman S. (2025) “CpG island methylator phenotype classification improves risk assessment in pediatric T-cell acute lymphoblastic leukemia.” Blood, 8 May 2025, doi: 10.1182/blood.2024026027. Link:

 

Disclaimer: The news stories shared on this site are used as a way to inform our members and followers of updates and relevant information happening in 91. The BSH does not endorse the content of news items from external sources, and is not in a position to verify the findings, accuracy or the source of any studies mentioned. Any medical or drugs information is provided as an information resource only, and is not to be relied on for any diagnostic or treatment purposes.

News service provided by .